Tumor metabolic reprogramming in lung cancer progression

Area of Science:

• Oncology
• Molecular Biology
• Metabolism

Background:

• Metabolic reprogramming is a hallmark of cancer, enabling tumor cells to meet the high demands of proliferation.
• Altered metabolic pathways, including glucose, glutamine, and lipid metabolism, are crucial for tumor growth, survival, and drug resistance.
• Understanding these metabolic shifts is vital for developing effective cancer therapies.

Purpose of the Study:

• To review the abnormal metabolic changes in glucose, fat, and amino acid metabolism in lung cancer.
• To elucidate the underlying molecular mechanisms driving metabolic reprogramming in lung cancer.
• To provide novel insights for the prevention, early diagnosis, and treatment of lung cancer.

Main Methods:

• Literature review of studies on metabolic reprogramming in cancer, with a focus on lung cancer.
• Analysis of molecular mechanisms underlying altered glucose, lipid, and amino acid metabolism.
• Synthesis of current knowledge on targeting metabolic pathways for therapeutic benefit.

Main Results:

• Tumor cells exhibit significant alterations in glucose, glutamine, and lipid metabolism to support rapid proliferation.
• Metabolic reprogramming influences gene expression, cell state, and the tumor microenvironment, promoting tumor growth.
• These metabolic changes are implicated in the growth advantage and chemotherapy tolerance observed in lung cancer.

Conclusions:

• Targeting metabolic reprogramming pathways presents a promising strategy for inhibiting tumor growth and inducing apoptosis in lung cancer.
• A comprehensive understanding of metabolic alterations can guide the development of novel therapeutic interventions.
• This review highlights the potential of targeting tumor cell metabolism for improved lung cancer management.